Study of a dye to check ureters during surgery in people with kidney problems
Treatments studied
Part of Injuries & trauma, Kidney & urinary clinical trials.
This trial tests a blue dye (Bludigo) to help doctors see if the ureters are open during surgery. It is for people with normal or reduced kidney function who need a procedure where the ureters are checked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You are scheduled for a surgery where the doctor needs to look at your ureters with a scope.
- Your kidney function is normal or has mild to severe impairment (but not end-stage).
- If your kidneys are impaired, the condition must be stable (no sudden worsening in the last 2 months).
- You are not allergic to Bludigo or other blue/contrast dyes.
- You have two working kidneys and are not expected to need dialysis soon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blue dye (Indigotindisulfonate Sodium) given during surgery to help doctors see if the tube from your kidney to bladder (ureter) is open. It's for people who are already having a surgery where that check is needed.
This trial tests a blue dye (Indigotindisulfonate Sodium) given during surgery to help doctors see if the ureters (tubes from kidneys to bladder) are open. It's for children having urological or gynecological procedures.
This trial tests an injection called IS-001 during robotic-assisted colorectal surgery. It may help surgeons see the ureters more clearly, which could reduce the risk of injury.
This trial tests a dye called Nizaracianine Triflutate that helps surgeons see the ureters (tubes from kidneys to bladder) during surgery. It aims to make surgery safer by reducing the risk of accidentally injuring the ureters.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
This study tests if a simple blood test (cystatin) can detect kidney damage earlier in people with chronic kidney disease who receive contrast dye for imaging. It could help doctors act faster to protect kidneys.
Hear when a new Ureter Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.